Janus Henderson Group PLC Neurocrine Biosciences Inc Transaction History

Janus Henderson Group PLC

$174 Billion
Q1 2025

A detailed history of Janus Henderson Group PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 783,966 shares of NBIX stock, worth $96.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

783,966

Previous 794,118 1.28%

Holding current value

$96.4 Million

Previous $108 Million 20.01%

% of portfolio

0.05%

Previous 0.06%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$107.22 - $153.29 $1.09 Million - $1.56 Million	-10,152 Reduced 1.28%	783,966 $86.7 Million
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $214,533 - $268,003	1,922 Added 0.24%	794,118 $108 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $20.5 Million - $27.4 Million	-179,007 Reduced 18.43%	792,196 $91.2 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $53.3 Million - $58.3 Million	-407,310 Reduced 29.55%	971,203 $134 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $22.5 Million - $24.8 Million	-172,854 Reduced 11.14%	1,378,513 $190 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $17.6 Million - $22 Million	-165,687 Reduced 9.65%	1,551,367 $204 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $18 Million - $22.5 Million	-191,790 Reduced 10.05%	1,717,054 $193 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $7.67 Million - $8.98 Million	-85,677 Reduced 4.3%	1,908,844 $180 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $39.6 Million - $51.8 Million	-421,117 Reduced 17.43%	1,994,521 $202 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $268 Million - $319 Million	-2,511,196 Reduced 50.97%	2,415,638 $289 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $26.4 Million - $30.9 Million	-286,900 Reduced 5.5%	4,926,834 $523 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $83.1 Million - $110 Million	-1,096,029 Reduced 17.37%	5,213,734 $508 Million
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $82.3 Million - $108 Million	-1,136,076 Reduced 15.26%	6,309,763 $592 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $123 Million - $164 Million	-1,540,472 Reduced 17.14%	7,445,839 $634 Million
Q3 2021 Nov 16, 2021	BUY	$86.18 - $99.03 $2.95 Million - $3.39 Million	34,237 Added 0.38%	8,986,311 $862 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $25 Million - $28.6 Million	-279,215 Reduced 3.02%	8,952,074 $871 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $6.14 Million - $8.38 Million	70,148 Added 0.77%	9,231,289 $898 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $227 Million - $283 Million	2,612,748 Added 39.9%	9,161,141 $878 Million
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $5.21 Million - $7.33 Million	54,202 Added 0.83%	6,548,393 $630 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $96.6 Million - $148 Million	-1,135,008 Reduced 14.88%	6,494,191 $792 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $19.2 Million - $29.1 Million	255,687 Added 3.47%	7,629,199 $660 Million
Q4 2019 Feb 18, 2020	SELL	$86.8 - $118.57 $98.1 Million - $134 Million	-1,130,024 Reduced 13.29%	7,373,512 $793 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $71.1 Million - $86.1 Million	-848,704 Reduced 9.07%	8,503,536 $766 Million
Q2 2019 Jul 31, 2019	BUY	$72.24 - $91.27 $39 Million - $49.3 Million	540,279 Added 6.13%	9,352,240 $790 Million
Q1 2019 Apr 30, 2019	BUY	$69.31 - $91.53 $315,152 - $416,186	4,547 Added 0.05%	8,811,961 $776 Million
Q4 2018 Feb 06, 2019	BUY	$68.32 - $124.36 $112 Million - $205 Million	1,644,949 Added 22.97%	8,807,414 $629 Million
Q3 2018 Nov 09, 2018	SELL	$98.88 - $125.85 $25 Million - $31.8 Million	-252,396 Reduced 3.4%	7,162,465 $881 Million
Q2 2018 Aug 10, 2018	SELL	$75.3 - $105.99 $3.7 Million - $5.21 Million	-49,133 Reduced 0.66%	7,414,861 $728 Million
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $128 Million - $156 Million	1,691,883 Added 29.31%	7,463,994 $619 Million
Q4 2017 Feb 09, 2018	BUY	$58.53 - $77.59 $15.5 Million - $20.5 Million	264,348 Added 4.8%	5,772,111 $448 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $6.75 Million - $8.62 Million	140,639 Added 2.62%	5,507,763 $0
Q2 2017 Aug 17, 2017	BUY	N/A	5,367,124	5,367,124 $247 Million

Others Institutions Holding NBIX

# of Institutions

650

Shares Held

97.2M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Neurocrine Biosciences Inc Transaction History